29-Jul-2024 Genomic Biotech
To Considered and approved the standalone Un-Audited financial results of the Company for the quarter ended 30th June 2024. A copy of the said standalone Un-audited financial results along with the Limited review report from statuary auditor is enclosed herewith.
16 min read•By Value Research
3 min read•By Dhirendra Kumar
4 min read•By Value Research
Please subscribe to Value Research Premium to unlock the custom duration feature and enhance your experience.
Recommendations for the best investments and allocations that are most optimal for your goal
Backed by research by a team of investment experts with over 30 years of experience
Continuous analysis and support from our team to make sure your goals stay on track
Widely read:
